Rankings
▼
Calendar
XNCR Q2 2016 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena
XNCR
Xencor, Inc.
$883M
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$66M
Gross Profit
$52M
78.2% margin
Operating Income
$49M
73.6% margin
Net Income
$47M
71.5% margin
EPS (Diluted)
$1.13
QoQ Revenue Growth
+810.2%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$10M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$334M
Total Liabilities
$126M
Stockholders' Equity
$209M
Cash & Equivalents
$8M
← FY 2016
All Quarters
Q3 2016 →